Syntiron

Early-stage biotech R&D company focused on human vaccines based on iron-regulated bacterial proteins

placeSaint Paul, Minnesota, United States calendar_todayFounded 2004 language syntiron.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace active. Cited 3 times.

YearFilings
20241
20251
20261

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon